ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Vaidya Sane Ayurved Laboratories filed a statement of deviation or variation in fund utilization pursuant to Regulation 32(1) for the quarter ended June 30, 2026.
Vaidya Sane Ayurved Laboratories Limited informed the exchange regarding the non-applicability of Corporate Governance provisions under SEBI LODR Regulation 27. The company is exempted as it is listed on the NSE SME portal and meets the threshold criteria of having paid-up equity capital under ₹10 crore and net worth under ₹25 crore.
Vaidya Sane Ayurved Laboratories Limited submitted an undertaking regarding the non-applicability of SEBI Corporate Governance regulations for the fiscal year ended March 31, 2026. As an SME-listed entity on the NSE, the company is exempted under Regulation 15 of SEBI (LODR) Regulations, 2015.
Vaidya Sane Ayurved Laboratories Limited's promoters have submitted their annual disclosure for the period ended March 31, 2026. The filing confirms that no encumbrance, direct or indirect, was created on the promoter group's shareholding during the year, maintaining a stable pledge-free ownership structure.